glp 1 lower inflammation GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Should I take a GLP-1

Nonetheless, the same mechanismsparticularly delayed gastric emptying and central satiety signalsalso underlie a wide spectrum of GI side effects, ranging from mild and transient symptoms to clinically significant complications such as gastroparesis and acute pancreatitis

Obesity is a major risk factor for heart disease, and GLP-1 medications can help with weight loss

The standard framing treats the risk of the medication as the only risk in the equation and ignores the risk of leaving obesity untreated

Differential effect of exogeneous glutathione on susceptibility of non-beta-lactam antibiotics in clinical isolates of OXA-type carbapenemase-producing Acinetobacterbaumannii

A meta-analysis of 16 studies showed that subclinical hypothyroidism generally did not increase the risk of most cardiac problems apart from mortality from ischaemic heart disease

Hong TT, Zhao W, He, et al